In a study involving whole exome sequencing analysis of 87 tumor samples from 49 patients with metastatic melanoma that were treated with PD-1 and CTLA-4 inhibitors, patients who developed colitis were found to have tumors that were enriched with 14 mutated genes compared with patients who did not develop colitis [91]. This evidence concerns the gene CTLA4 and metastatic melanoma.